Glenn Wilkins - Monday, November 6, 2017 Trillium Therapeutics Inc. 11:34 AM EST - Trillium Therapeutics Inc. : Is scheduled to present an update on the company's programs and progress at several upcoming scientific conferences. Trillium Therapeutics Inc. shares T.TRIL are trading up $1.00 at $12.50.